Synergistic and Antagonistic Drug Combinations against SARS-CoV-2
Tesia Bobrowski(Center for Migration Studies of New York), Eugene Muratov(University of North Carolina at Chapel Hill), Matthew D. Hall(National Institutes of Health), Wei Zheng(Liaoning Cancer Hospital & Institute), Zina Itkin(National Institutes of Health), Sam Michael(National Institutes of Health), Anton Simeonov(National Institutes of Health), Alexey Zakharov(Imperial College London), Lu Chen(Beijing Biocytogen (China)), Hui Guo(First Affiliated Hospital of Xi'an Jiaotong University), Catherine Z. Chen(National Institutes of Health), Paul Shinn(National Institutes of Health), Richard T. Eastman(National Institutes of Health)
Cited by 127
Related Papers
QSAR without borders
|Chemical Society Reviews|2020|846
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium
|Cell stem cell|2020|460
Chalcone Derivatives: Promising Starting Points for Drug Design
|Molecules|2017|415
Unexplored therapeutic opportunities in the human genome
|Nature Reviews Drug Discovery|2018|391